Public Company News

The First in the Global Lidar Industry: Hesai Obtained ISO 21448 Intended Functional Safety Process Certification

PALO ALTO, Calif., Sept. 9, 2024 /PRNewswire/ -- Hesai Technology, a global leader in the lidar industry, has successfully passed a rigorous audit by TÜV SÜD and obtained the ISO 21448 Safety of the Intended Functionality (SOTIF) certification based on ISO 26262 functional safety and a QMS framew...

2024-09-09 20:00 2887

Sirsram Medical announces NMPA approval for DAXXIFY®

Marking the introduction of the world's first and only peptide-powered  botulinum toxin product to Mainland China HONG KONG, Sept. 9, 2024 /PRNewswire/ -- Sisram Medical (1696.HK), a global leading innovator and provider of holistic medical aesthetic solutions announced today that the National M...

2024-09-09 19:46 4193

Zhihu Inc. Commences Tender Offers to Buy Back Up to US$54.8 Million of Its Class A Ordinary Shares and American Depositary Shares

BEIJING, Sept. 9, 2024 /PRNewswire/ -- Zhihu Inc. (NYSE: ZH; HKEX: 2390) ("Zhihu" or the "Company"), a leading online content community inChina, today announced that it has commenced all cash tender offers (the "Offers") to buy back up to 46,921,448 Class A ordinary shares of the Company (includi...

2024-09-09 17:39 4031

Acer Announces August Consolidated Revenues at NT$22.82 Billion, Up 5.2% Year-on-year

TAIPEI, Sept. 9, 2024 /PRNewswire/ -- Acer Inc. (TWSE: 2353) announced its consolidated revenues for August atNT$22.82 billion with 5.24% growth year-on-year (YoY), achieving 14 consecutive months of YoY growth. Consolidated revenues for year-to-August reachedNT$172.28 billion with 14.8% growth Y...

2024-09-09 16:54 3386

CHiQ Renews Sponsorship of FIS World Cup Events, Welcomes Skiing Champion Andreas Wellinger as New Brand Ambassador

BERLIN, Sept. 9, 2024 /PRNewswire/ -- On September 6, coinciding with the opening of the IFA 2024, CHiQ held a ceremonial signing at its booth, reaffirming its partnership with the FIS World Cup Events and the German Ski Association (DSV). The move strengthens CHiQ's foothold in the skiing world ...

2024-09-09 16:02 3639

Changhong's Innovative Technologies Take Center Stage at IFA 2024, Marking New Milestones in Global Growth

BERLIN, Sept. 9, 2024 /PRNewswire/ -- At IFA 2024, which opened on September 6, Changhong, a leading force inChina's home appliance industry, introduced its entire suite of AI-driven appliances. The presentation not only showcased Changhong's recent achievements in AI technology but also marked a...

2024-09-09 15:38 3685

Ping An Selected for Hang Seng Corporate Sustainability Index. Series for 14th Consecutive Year

HONG KONG and SHANGHAI, Sept. 9, 2024 /PRNewswire/ -- Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 2318 / 82318; SSE: 601318) has been included as a constituent member in the Hang Seng Corporate Sustainability Index Series for 2024-2025...

2024-09-09 15:18 3845

Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization

TAIPEI, Sept. 9, 2024 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. (hereinafter referred to as "Formosa Pharma," 6838.TW) announced the successful first shipment tothe United States of its new ophthalmic drug, Clobetasol Propionate Ophthalmic Suspension, 0.05% (APP13007), manufactured by Bora P...

2024-09-09 15:00 2857

Clarivate Report Unveils the Transformative Role of Artificial Intelligence on Shaping the Future of the Library

LONDON, Sept. 9, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today launched its firstPulse of the LibraryTM report. The report reveals that libraries are in the early days of Artificial Intelligence (AI) implementation. Librarians are ...

2024-09-09 15:00 2160

Three Study Results Abstracts From Kelun-Biotech's TROP2-ADC SKB264 (sac-TMT) At 2024 ESMO Released Today

CHENGDU, China, Sept. 9, 2024 /PRNewswire/ -- The European Society for Medical Oncology (ESMO) Congress 2024 will be held inBarcelona, Spain from September 13 to 17, 2024. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd("Kelun-Biotech", 6990.HK)will present the following results of its anti-TROP...

2024-09-09 14:27 2981

EQT to acquire GeBBS Healthcare Solutions, a leading healthcare technology solutions provider

* GeBBS Healthcare Solutions ("GeBBS" or the "Company") specializes in revenue cycle management, health information management (HIM), and medical billing services * It offers a range of services designed to help US-based healthcare providers, including hospitals, health systems, and physician...

2024-09-09 14:03 2713

MARRIOTT INTERNATIONAL CELEBRATES ITS 50TH PROPERTY IN MALAYSIA, WITH THE DEBUT OF THE PENANG MARRIOTT COMPLEX

This landmark development is comprised of three distinguished properties – Penang Marriott Hotel, Marriott Executive Apartments Penang, and Marriott Residences Penang GEORGE TOWN, Malaysia, Sept. 9, 2024 /PRNewswire/ -- Marriott International, Inc. announced the opening of Penang Marriott Comple...

2024-09-09 11:38 3681

Hilton Bali Resort Unveils Elara Seaside Lounge and Bar, an Oasis of Mediterranean Sophistication in Nusa Dua

BALI, Indonesia, Sept. 9, 2024  /PRNewswire/ -- Hilton Bali Resort , a 27-acre cliffside retreat in sereneNusa Dua, has expanded its prestigious collection of dining venues with the launch of Elara, a new adults-only seaside lounge and...

2024-09-09 10:59 3305

CHiQ Awarded TÜV Carbon Verification Statement for Its Products, Showcasing New Trends in Eco-Friendly Living

BERLIN, Sept. 9, 2024 /PRNewswire/ -- On September 6th, at the 2024 IFA exhibition, the internationally renowned organization TÜV awarded CHiQ two certificates. These include the Organizational Greenhouse Gas Verification Statement and the Product Carbon Footprint Verification Statement for refr...

2024-09-09 10:34 3100

Senhwa Biosciences Presents Clinical Data Abstract on Pidnarulex at 2024 ESMO Congress

* The study involved end-stage oncology patients with no other suitable treatment options. * In this Phase Ib study, Pidnarulex (CX-5461) demonstrated acceptable clinical tolerability and showed preliminary signs of efficacy, even in patients who had previously failed treatment with PARP inhi...

2024-09-09 10:33 3303

TCL Presents Extensive Product Portfolio and Innovative Technologies for a Smarter and Healthier Lifestyle at IFA 2024

BERLIN, Sept. 9, 2024 /PRNewswire/ -- TCL Electronics, a leading consumer electronics company and the world's top two TV brand presented its latest range of innovative technologies at IFA 2024 inBerlin, featuring one of its most extensive product lineups. As IFA marked its 100th anniversary, TCL ...

2024-09-09 10:26 4987

Roborock Unveils Next-Generation Floor Cleaning Solutions in Australia: Meet Qrevo Master, Qrevo S, and H5

Roborock continues its cleaning evolution in Australia with the launch of Qrevo Master, Qrevo S, and H5, offering Australians advanced cleaning technology just in time for spring cleaning. SYDNEY, Sept. 9, 2024 /PRNewswire/ -- Roborock , a global leader in ultra-int...

2024-09-09 10:00 3702

ESMO 2024 | Ascentage Pharma to Present Updated Data of Olverembatinib in Patients with SDH-Deficient GIST during a Mini Oral Presentation at the 2024 ESMO Congress

ROCKVILLE, Md. and SUZHOU, China, Sept. 9, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for malignancies, today announced that it will present the latest c...

2024-09-09 08:25 4173

Major Release of Veeva Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors

New capabilities and simple, standard site experience cut trial time and expense Fixed price implementation to get up and running quickly Industry advances to connected trials as seven of the top 20 biopharmas adopt Veeva Site Connect SEOUL, South Korea, Sept. 9, 2024 /PRNewswire/ -- Veeva System...

2024-09-09 08:00 4642

Major Release of Veeva Site Connect Streamlines Clinical Trial Execution for Sites and Sponsors

New capabilities and simple, standard site experience cut trial time and expense Fixed price implementation to get up and running quickly Industry advances to connected trials as  seven of the top 20 biopharmas adopt Veeva Site Connect SYDNEY, Sept. 9, 2024 /PRNewswire/ -- Veeva Systems

2024-09-09 07:00 3563